LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

Celldex Therapeutics Inc

Closed

SectorHealthcare

24.88 -2.7

Overview

Share price change

24h

Current

Min

24.52

Max

25.57

Key metrics

By Trading Economics

Income

-10M

-67M

EPS

-1.01

Profit margin

-7,753.425

Employees

186

EBITDA

-3.2M

-66M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+105.43% upside

Market Stats

By TradingEconomics

Market Cap

222M

1.7B

Previous open

27.58

Previous close

24.88

News Sentiment

By Acuity

50%

50%

177 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Celldex Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

19 Nov 2025, 23:36 UTC

Hot Stocks

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 Nov 2025, 22:13 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 Nov 2025, 21:55 UTC

Major Market Movers

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 Nov 2025, 21:43 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 Nov 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19 Nov 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 Nov 2025, 23:47 UTC

Earnings

Lenovo Group 2Q EPS $2.52 >0992.HK

19 Nov 2025, 23:46 UTC

Earnings

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 Nov 2025, 23:45 UTC

Earnings

Lenovo Group 2Q Rev $20.5B >0992.HK

19 Nov 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 Nov 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19 Nov 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 Nov 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 Nov 2025, 23:40 UTC

Earnings

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 Nov 2025, 22:55 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 Nov 2025, 22:41 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 Nov 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 Nov 2025, 22:30 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 Nov 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 Nov 2025, 22:27 UTC

Acquisitions, Mergers, Takeovers

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 Nov 2025, 22:08 UTC

Earnings

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 Nov 2025, 22:00 UTC

Earnings

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 Nov 2025, 21:58 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 Nov 2025, 21:52 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 Nov 2025, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

19 Nov 2025, 21:49 UTC

Market Talk
Earnings

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 Nov 2025, 21:38 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 Nov 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B

19 Nov 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 Nov 2025, 21:24 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Peer Comparison

Price change

Celldex Therapeutics Inc Forecast

Price Target

By TipRanks

105.43% upside

12 Months Forecast

Average 52.55 USD  105.43%

High 90 USD

Low 21 USD

Based on 12 Wall Street analysts offering 12 month price targets forCelldex Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

0

Hold

1

Sell

Technical Score

By Trading Central

18.91 / 20.63Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

177 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
help-icon Live chat